Comorbidity and survival of Danish breast cancer patients from 2000-2011: A population-based cohort study

Clinical Epidemiology

Volumn 5, Issue SUPP 1, 2013, Pages 39-46

  Ording, Anne Gulbech ^a   Cronin Fenton, Deirdre P ^a   Jacobsen, Jacob Bonde ^a   Nørgaard, Mette ^a   Thomsen, Reimar Wernich ^a   Christiansen, Peer ^a   Søgaard, Mette ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Breast neoplasm; Comorbidity; Mortality; Prognosis; Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; DENMARK; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEMIPLEGIA; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MORTALITY; OVERALL SURVIVAL; PERIPHERAL VASCULAR DISEASE; PREDICTOR VARIABLE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; ULCER;

EID: 84887140718     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S47152     Document Type: Article

References (26)

1. Organisation for Economic Co-operation and Development. Health at a Glance: Europe 2012. Available from: http://dx.doi.org/10.1787/9789264183896-en. Accessed July 12, 2013.
2. Engholm G, Ferlay J, Christensen N, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725-736.
3. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35(3):181-200.
4. Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88(3):653-663.
5. Cronin-Fenton DP, Nørgaard M, Jacobsen J, et al. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer. 2007;96(9):1462-1468.
6. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101-1111.
7. Ring A, Sestak I, Baum M, et al. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial. J Clin Oncol. 2011;29(32): 4266-4272.
8. Riihimaki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. Death causes in breast cancer patients. Ann Oncol. 2012;23(3):604-610.
9. Bush D, Smith B, Younger J, Michaelson JS. The non-breast-cancer death rate among breast cancer patients. Breast Cancer Res Treat. 2011;127(1):243-249.
10. Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28(12):2038-2045.
11. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005;55(3):231-240.
12. Jørgensen TL, Hallas J, Friis S, Herrstedt J. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer. 2012;106(7):1353-1360.
13. Lietzen LW, Sørensen GV, Ording AG, et al. Survival of women with breast cancer in central and northern Denmark, 1998-2009. Clin Epidemiol. 2011;3 Suppl 1:35-40.
14. Land LH, Dalton SO, Jensen MB, Ewertz M. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat. 2012;131(3): 1013-1020.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
16. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(Suppl 7):22-25.
17. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(Suppl 7):30-33.
18. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007;17(8):584-590.
19. Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer. 2004;40(16):2494-2501.
20. [Short and long term survival after hospitalization for selected cancer diseases in North Jutland County, Viborg County and Aarhus County.] Kort-og Langtidsoverlevelse Efter Indlæggelse for Udvalgte Kræftsygdomme i Nordjyllands, Viborg og Århus Amter 1985-2003. Department of Clinical Epidemiology, Aarhus University Hospital; 2004. Available from: http://kea.au.dk/files/28.pdf. Accessed January 21, 2013. Danish.
21. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
22. Gonzalez EC, Ferrante JM, Van Durme DJ, Pal N, Roetzheim RG. Comorbid illness and the early detection of cancer. South Med J. 2001;94(9):913-920.
23. Yasmeen S, Xing G, Morris C, Chlebowski RT, Romano PS. Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer. 2011;117(14):3252-3261.
24. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285(7):885-892.
25. Berglund A, Wigertz A, Adolfsson J, et al. Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat. 2012;135(1):281-289.
26. Hancke K, Denkinger MD, König J, et al. Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol. 2010;21(4):748-753.